Tumor immunotherapy: the tumor cell as an antigen-presenting cell
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 6 (5) , 722-727
- https://doi.org/10.1016/0952-7915(94)90075-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor AntigensScience, 1994
- Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytesNature, 1994
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- Cancer vaccinesImmunology Today, 1993
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984